Glycosylated and non-glycosylated recombinant human granulocyte colony-stimulating factor (rhG-CSF)—what is the difference?
✍ Scribed by Martin Höglund
- Publisher
- Springer US
- Year
- 1998
- Tongue
- English
- Weight
- 515 KB
- Volume
- 15
- Category
- Article
- ISSN
- 1357-0560
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract We studied the effects of __in vivo__ administrations of recombinant human granulocyte colony‐stimulating factor (rhG‐CSF) on the metastasis of murine hematogenous and non‐hematogenous tumors in spontaneous and experimental metastasis models. Spontaneous lung metastasis caused by intra‐
Limited evidence suggests increased efficacy of rhG-CSF by subcutaneous (SQ) compared with intravenous (IV) administration. To examine the possibility that rapid elimination of IV rhG-CSF could substantially shorten the duration of systemic exposure and could explain a difference in pharmacodynamics
## Abstract A trypsin‐resistant core peptide of recombinant human granulocyte‐macrophage colony‐stimulating factor (rhGM‐CSF) was isolated and analyzed by high‐energy Cs^+^ liquid secondary‐ion (LSI) mass spectrometric analysis. This analysis provided successful detection of the high‐mass disulfide